tobramycin has been researched along with azlocillin in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (79.63) | 18.7374 |
1990's | 6 (11.11) | 18.2507 |
2000's | 3 (5.56) | 29.6817 |
2010's | 2 (3.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barrow, K; Kwon, DH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Daschner, FD; Langmaack, H; Steffens, A | 1 |
Kallfelz, HC; Oppermann-Paul, K; Paul, T; Peltner, HU | 1 |
Moss, RB | 1 |
Malottke, R; Steinkamp, G; Tümmler, B; von der Hardt, H | 1 |
Ehrich, JH; Gröne, HJ; Lütge, M; Schulz-Baldes, JG; Steinkamp, G; Wurster, U | 1 |
Gratz, JC; Maserati, R; Scheld, WM; Strunk, RW | 1 |
Chalkley, LJ; Koornhof, HJ | 1 |
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
Watanakunakorn, C | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Escalona, L; Goldmann, D; L'Heureux, C; Macone, A; Maduri-Traczewski, M | 1 |
Rubio, TT; Shapiro, C | 1 |
Chan, EL; Zabransky, RJ | 1 |
Andriole, VT; Johnson, M; Miniter, P | 1 |
Black, PG; Bosso, JA | 1 |
Garty, I; Holdstein, Y; Rosen, G | 1 |
Overbeek, BP; Rozenberg-Arska, M; Verhoef, J | 1 |
Mellinghoff, D; Shah, PM; Stille, W | 1 |
Bosso, JA; Walker, KB | 1 |
Heimesaat, M; Kljucar, S; Olms, K; von Pritzbuer, E | 1 |
Black, PG; Bosso, JA; Matsen, JM | 1 |
Rubio, TT | 1 |
Davidson, S; Nakatomi, M; Neu, HC; Ores, C; Scully, BE | 1 |
Cunitz, D; Fox, N; Lowenbraun, S | 1 |
Oliver, AM; Weir, DM | 1 |
Bricaire, F; Bure, A; Humbert, G; Vachon, F; Vilde, JL | 1 |
Knothe, H | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Fass, RJ | 1 |
Asphaug Kjellevold, V; Dibb, WL; Digranes, A | 1 |
Goldmann, DA; Matthews, WJ; McLaughlin, FJ; Murphy, P; Strieder, DJ; Sullivan, B; Taneja, A | 1 |
Goldmann, DA; Matthews, WJ; McLaughlin, FJ; Strieder, DJ; Sullivan, B | 1 |
Duerden, BI; Lilleyman, JS; Morgan, G | 1 |
Creger, RJ; Falkowski, AJ | 1 |
Drake, TA; Hackbarth, CJ; Rusnak, MG; Sande, MA | 1 |
Pickering, LK; Rutherford, I | 1 |
Henderson, JL; Kline, BJ; Polk, RE | 1 |
Eriksen, KR; Feddersen, C; Flensborg, EW; Høiby, N; Møller, NE; Norn, S; Rosendal, K; Schiøtz, PO; Skov, PS | 1 |
Pennington, JE; Schiff, JB | 1 |
Alfredsson, H; Malmborg, AS; Strandvik, B | 1 |
Norden, CW; Shaffer, MA | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Matzkowitz, AJ; Smith, RP; Sutphen, NT | 1 |
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G | 1 |
Breyer, S; Graninger, W; Pauser, G; Pichler, H; Pirich, U | 1 |
Shah, PM; Siegel, K; Stille, W | 1 |
Li Wan Po, A; McFarland, MM; Scott, EM | 1 |
Doershuk, C; Goldmann, D; Gore, E; Hilman, B; Marks, M; Moss, R; Ramsey, B; Redding, G; Rubio, T; Smith, AL; Williams-Warren, J; Wilmott, R; Wilson, HD; Yogev, R | 1 |
Po, AL; Scott, EM; Tariq, VN; Wu, YL | 2 |
10 trial(s) available for tobramycin and azlocillin
Article | Year |
---|---|
Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Azlocillin; Aztreonam; Ceftazidime; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Immunoglobulin G; Male; Piperacillin; Skin Tests; Ticarcillin; Tobramycin | 1991 |
Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis.
Topics: Adolescent; Azlocillin; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Liver; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections; Sputum; Tobramycin; Transaminases | 1988 |
[Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
Topics: Adult; Azlocillin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Opportunistic Infections; Pneumonia; Random Allocation; Respiration, Artificial; Tobramycin | 1987 |
Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Random Allocation; Therapeutic Equivalency; Tobramycin | 1987 |
Ciprofloxacin: comparative data in cystic fibrosis.
Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Penicillin Resistance; Pseudomonas Infections; Tobramycin | 1987 |
Ciprofloxacin therapy in cystic fibrosis.
Topics: Adolescent; Adult; Azlocillin; Child; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Pseudomonas Infections; Tobramycin | 1987 |
Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Azlocillin; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Humans; Lung; Penicillin Resistance; Penicillins; Random Allocation; Ticarcillin; Tobramycin | 1983 |
Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
Topics: Adolescent; Adult; Aged; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Humans; Lung Diseases; Middle Aged; Penicillins; Random Allocation; Respiratory Function Tests; Sputum; Ticarcillin; Tobramycin | 1983 |
Ceftazidime as a single agent in the management of children with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Anemia, Aplastic; Azlocillin; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neoplasms; Neutropenia; Penicillins; Random Allocation; Tobramycin | 1983 |
Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Azlocillin; Child; Cystic Fibrosis; DNA, Bacterial; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Penicillins; Pseudomonas aeruginosa; Respiratory Function Tests; Sputum; Tobramycin; Vital Capacity | 1999 |
44 other study(ies) available for tobramycin and azlocillin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Topics: Amikacin; Aminoglycosides; Azlocillin; Drug Synergism; Escherichia coli; Gentamicins; Imidazolidines; Klebsiella pneumoniae; Netilmicin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1979 |
[Experiences with triple antibiotic combination in neonatal infection].
Topics: Azlocillin; Bacteriological Techniques; Cefotaxime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1992 |
Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.
Topics: Adolescent; Azlocillin; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Serotyping; Sputum; Time Factors; Tobramycin | 1989 |
Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; Azlocillin; CD13 Antigens; Child; Child, Preschool; Creatinine; Cystic Fibrosis; Female; Hexosaminidases; Humans; Kidney; Male; Proteinuria; Pseudomonas Infections; Tobramycin | 1986 |
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Tobramycin | 1985 |
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Topics: Azlocillin; Aztreonam; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Tobramycin | 1985 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Topics: Azlocillin; Carbenicillin; Dose-Response Relationship, Drug; Drug Combinations; Gentamicins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.
Topics: Anti-Bacterial Agents; Azlocillin; Culture Media; Cystic Fibrosis; Humans; Penicillin Resistance; Pseudomonas aeruginosa; Sputum; Ticarcillin; Tobramycin | 1986 |
Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin | 1986 |
Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Topics: Azlocillin; Ceftazidime; Colistin; Drug Synergism; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1987 |
Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
Topics: Animals; Azlocillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
The radionuclide diagnosis, evaluation and follow-up of malignant external otitis (MEO). The value of immediate blood pool scanning.
Topics: Aged; Azlocillin; Diphosphonates; Gallium Radioisotopes; Humans; Male; Mastoid; Otitis Externa; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Temporal Bone; Tobramycin | 1985 |
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.
Topics: Acinetobacter; Azlocillin; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Quinolines; Tobramycin | 1985 |
[Ciprofloxacin in combination with other antimicrobial substances].
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Drug Interactions; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1988 |
Lack of correlation between objective indicators and clinical-response scores during antimicrobial therapy for acute pulmonary exacerbations of cystic fibrosis.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Ciprofloxacin; Cystic Fibrosis; Humans; Tobramycin | 1988 |
Azlocillin, cephalothin, and tobramycin therapy in febrile solid tumor patients with chemotherapy-induced leukopenia.
Topics: Adult; Aged; Aged, 80 and over; Azlocillin; Bacterial Infections; Cephalothin; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Tobramycin | 1987 |
The in vitro effect of three antibiotics on alveolar macrophages.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Cells, Cultured; Macrophages; Male; Phagocytosis; Rats; Rats, Inbred Strains; Rosette Formation; Ticarcillin; Tobramycin | 1985 |
[Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Topics: Adolescent; Adult; Aged; Amikacin; Azlocillin; Drug Therapy, Combination; Female; Humans; Male; Meningitis; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1984 |
Sensitivity testing and synergy.
Topics: Azlocillin; Bacteria; Cefotaxime; Cephalosporins; Culture Media; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Tobramycin | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefotaxime; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Sepsis; Tobramycin | 1982 |
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1983 |
Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Topics: Azlocillin; Carbenicillin; Cefamandole; Drug Interactions; Humans; Hydroxylamine; Hydroxylamines; Immunoenzyme Techniques; In Vitro Techniques; Moxalactam; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1984 |
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Topics: Agranulocytosis; Aminoglycosides; Animals; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Netilmicin; Neutropenia; Penicillin Resistance; Penicillins; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1984 |
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin | 1981 |
In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
Topics: Anti-Bacterial Agents; Azlocillin; Carbenicillin; Chemistry, Pharmaceutical; Drug Incompatibility; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Temperature; Tobramycin | 1981 |
Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Topics: Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Tobramycin | 1982 |
Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Aztreonam; Guinea Pigs; Penicillins; Piperacillin; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1984 |
Azlocillin in cystic fibrosis.
Topics: Adolescent; Adult; Azlocillin; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1983 |
Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; Drug Therapy, Combination; Osteomyelitis; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1982 |
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[3d generation cephalosporins in nosocomial infections].
Topics: Adolescent; Adult; Aged; Azlocillin; Cephalosporins; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Tobramycin | 1983 |
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin | 1982 |
Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.
Topics: Azlocillin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1994 |
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1999 |
Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1999 |